CBDNewsBreaks – Earth Science Tech Inc. (ETST) Establishes New CBD Sales Division Concentrating on Therapeutic, Pharmaceutical-Grade Products

Earth Science Tech (OTCQB: ETST), an innovative biotechnology company, recently established a new sales division focusing specifically on CBD for therapeutic and pharmaceutical-grade products. An article discussing the company reads, “The impetus behind this new division comes from increased interest in CBD products across multiple medical communities, including medical, holistic and alternative medicine (http://cnw.fm/4c6Se). The division will be headed by Erika Franck, who has been serving as the company’s clinical and therapeutics sales director for several weeks. In her new role, Franck will be working with medical providers, chiropractors, acupuncturists, holistic-wellness practitioners and veterinarians, utilizing her years of experience in the medical field to bring the benefits of CBD to a myriad of industries.”

To view the full article, visit http://cnw.fm/yQPk6

About Earth Science Tech Inc.

Earth Science Tech offers the highest purity and quality high-grade, full-spectrum cannabinoid oil on the market. ETST notes positive results in studies on breast cancer and immune cells conducted through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the company’s CBD-oil formulation lowers cortisol and functions as a neuroprotectant, with positive-result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most-effective quality of CBD on the market. For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://cnw.fm/ETST

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – VPR Brands LP (VPRB) Considers Intellectual Property Licensing as Auto-Draw Technology Popularity Rises

VPR Brands (OTCQB: VPRB), a multivertical, tiered technology holding company in the cannabis space, is set to benefit as demand grows for e-cigarettes and vaping technologies. Internationally, the e-cigarette and vaping market was forecasted in 2018 to reach $10.3 billion and expand at a CAGR of 24.9% through 2025 (http://cnw.fm/7fkPJ). An article discussing the results reads, “The impressive rate at which the industry is growing has created an entrepreneurial attraction to newcomers in the space, causing a critical need for more established companies like VPR Brands to protect their trade secrets. . . . ‘The surge of the vaping category for nicotine, cannabis and CBD in the last few years has reached billions of dollars in sales,’ VPR Brands CEO Kevin Frija stated in a news release. ‘This has resulted in opportunities for our patented auto-draw technology, which we believe is now preferred by many users of pod systems and ‘cigalikes.’’ Frija added that these conditions have created an ‘opportune time to consider licensing, enforcement or potentially a sale of [the company’s] intellectual property to one of the larger players in the space who may then be in a better position to snub out many of the counterfeit or black-market vapes.’

To view the full article, visit http://cnw.fm/cd96V

About VPR Brands LP

VPR Brands is a technology company whose assets include issued U.S. and Chinese patents for atomization-related products including technology for medical-marijuana vaporizers and electronic-cigarette products and components. The company is also engaged in product development for the vapor or vaping market including e-liquids. Vaporizers and electronic cigarettes, also known as e-cigarettes, are devices that deliver nicotine and/or cannabis through atomization or vaping without smoke and other chemical constituents typically found in traditional products. For more information, visit the company’s website at www.VPRBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://cnw.fm/VPRB

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

HempNewsBreaks – SinglePoint, Inc. (SING) Lights Up NACS with Launch of Pure American Hemp(TM) Cigarettes

Technology and investment company SinglePoint (OTCQB: SING) today announced major success at the 2019 National Association of Convenience Stores show (“NACS”) in Atlanta. SinglePoint, as the master distributor of Pure American Hemp(TM) Cigarettes, sold multiple cases to retail store owners representing approximately 2500 stores during the show. In addition, SinglePoint was able to directly interact with interested store owners, national distributors and buying groups, accounting for well over 20,000 retail locations and, this week, has ordered additional product to meet demand. “Our success at NACS was beyond what anybody in our group imagined. It truly gave us deep insight to how large of an opportunity this is,” SinglePoint CEO Greg Lambrecht said in the news release. “With interest from parties representing over 20,000 retail locations we are excited to move into this convenience store industry accounting for over 150,000 locations. Over the next 90 days we will be following up with these owners to finalize their purchase orders. I am ecstatic to say that again we had people waiting in line to speak about our hemp cigarettes. It reminded me of the successful product introduction of Premium Cigars International and PrimeTime(TM) to the convenience store industry. We expect this new product to dramatically increase revenue in the near future.”

To view the full press release, visit http://cnw.fm/8iPrZ

About SinglePoint, Inc.

SinglePoint, Inc. is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing products and services to the cannabis industry. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Posts Credit Financing Update

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified-organic cannabis, today announced that it is reviewing alternative financing options to complete construction at its facilities in Ancaster, Ontario and phase 1a at Valleyfield, Quebec. Per the update, TGODF’s previously disclosed discussions for ordinary course commercial bank facilities and equipment leasing are no longer available on the acceptable terms within the timeframes required due to changing market conditions. Presently, the company has no debt and $56.7 million in cash available in Canada, including $40.2 million in restricted cash allocated to capital expenditures. Construction at Ancaster is mostly complete with all grow rooms licensed by Health Canada and approximately six weeks left before substantial completion of the processing facility. The company anticipates submitting the evidence package for this final component to Health Canada for licensing by the end of November. TGODF plans to prioritize any financing secured to hasten commercial production in order to increase revenues. If it is unable to secure enough financing on reasonable terms, within the required timeframe, the company may modify the construction schedule for its Ancaster and Valleyfield projects.

To view the full press release, visit http://cnw.fm/E3GDq

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium, global, organic-cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic-hemp, CBD-oil operations in Canada and, through its wholly owned subsidiary HemPoland, distributes premium-hemp CBD oil in the EU. The company grows high-quality, certified-organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,000 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://cnw.fm/TGOD

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Nearly a Thousand Businesses Sign Letter Asking Congress to Deschedule Marijuana

To mitigate the risks linked with vaping products purchased from the illicit markets, hundreds of leaders in the cannabis industry have signed a the letter for the descheduling of marijuana by Congress.

The letter is to be delivered on Thursday to the House and Senate leadership. The letter argues that the recent increases in injuries and deaths related to vaping are because there are no federal regulations on the sale and use of marijuana because marijuana remains to be a federally controlled substance. The injuries and death are a result of people using adulterated and unregulated weed.

The letter states that any death due to marijuana is one too many in the legal state-regulated marijuana industry. Therefore, to curb the illicit market and prevent future risks, the cannabis industry has to employ tools such as uniformity and good manufacturing practices.

The government should provide consumers with accurate and actionable information on the status of the illegal, untested, and dangerous marijuana products in the markets argued NCIA and its co-signers, who include companies such as Weedmaps, Berkeley Patients Group, SPARC, Leafly, and Vicente Sederberg LLP.

In an interview with a media outlet, the NCIA executive director, Aaron Smith, said that the members of Congress should understand that the failed prohibition policies permitting the continued operation of the unregulated underground market is the leading cause of the increase in the outbreak of vaping related illnesses.

He further stated that the regulation of alcohol at the federal and state level is the reason why there are no alcohol-related illnesses. Therefore, to improve state regulatory systems regarding marijuana and allow for comprehensive research on marijuana as well as limit the illicit market, it is essential for Congress to deschedule and regulate marijuana effectively.

To ensure that the citizens are not exposed to dangerous and untested marijuana products, the letter recommends the adoption of five policies.

First, the removal of cannabis from the Controlled Substances Act and start regulating marijuana in a sensible manner similar to that of alcohol. Moreover, make funds available for investigation of the illnesses by medical specialists in the state.

Secondly, to stop production of vaping equipment installed with thickening agents. The manufacturers should issue a recall of any vaping product that has Vitamin E acetate. Furthermore, licensed retailers should countercheck their stock to make sure they have no products containing Vitamin E acetate.

Thirdly, cannabis consumers should stop using vape cartridges obtained from illegal markets and cease future purchases of any vaping cartridges or products.

NCIA said that the other problem facing the industry is the federal regulations that prohibit legal marijuana businesses from forcing black market operators out of business. NCIA also added that the illicit activities would be disrupted and most probably removed from the markets by legitimate weed businesses if marijuana was removed from Controlled Substances Act.

According to Smith, the NCIA is ready to help the lawmakers and regulators ensure the safety of marijuana consumers. Industry analysts are of the view that companies like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America Inc. (OTCQB: MCOA) long for the day when the federal government finally acts on all the calls that have been made to reschedule marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Study Finds Youth Cannabis Use Reduced After Marijuana Legalization in Washington

A new study by Washington State found that the number of youths using marijuana has reduced following the state legalization of recreational marijuana.

According to the study, the number of students in grades six, eight, 10, and 12 in King County purchasing marijuana for personal use reduced or remained constant the whole of 2016. The consumption rate of the female students in grade 10 remained constant while that of the male students decreased. However, there was a spike up to four times the number of alcohol users among the users and non-users of cannabis.

The Centers for Disease Control and Prevention Morbidity and Mortality published the findings in their weekly report this Friday supporting past studies with similar results on the decline of marijuana use among the youths after legalization of recreational cannabis in Washington and other states in the U.S.

To assess the health risk behaviors of the youth, the department of health in Washington conducts a Washington State Health Survey among public school students in grades six, eight, 10, and 12 after every two years. While conducting their study, the researchers from Seattle and King County analyzed the data from 2004-2016 on substance abuse before making their conclusions.

The researchers established that there was a decline in the number of sixth-graders using marijuana in the past 30 days, while there was no change in the number of eighth-graders who used weed in those 30 days. The rate of the sophomores and seniors consuming cannabis increased in the year 2004-2012; however, the percentage decreased after marijuana was legalized for personal use in 2012. The findings from the survey contradict the opponents who thought that legalizing marijuana would pave the way for access to cannabis by teenagers.

From the analyzed data, they found that grade 10 students who admitted to using marijuana in the past month also used other substances such as alcohol, vape pens, and cigarettes. 67% used alcohol, 43% vape pens, and 24% cigarettes.

The reason why the rate of marijuana consumption among teens decreased is because of the reduction in the illicit supply of weed by introducing legal competitors in the markets. The youth may have also lost interest in the drug once it became legal. The government should also monitor other factors that prompt the use of marijuana, such as association with family and friends.

The decline or constant state of marijuana consumption was also evident in the state of Colorado and Oregon, who legalized recreational marijuana in 2013 and 2014, respectively.

Analysts agree that marijuana industry players like Neutra Corp. (OTCQB: NTRR) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) feel vindicated that research has shown that legalization of marijuana was never a ploy to get kids using marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Blissco Wellness Brand Receives Cannabis Oil Sales License

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its premium wellness brand and a multi-licensed processor and distributor, Blissco Cannabis Corp., has received Health Canada licensing approval for the sale of cannabis oils from its facility in Langley, British Columbia. According to the update, the license allows Blissco to sell full spectrum cannabidiol (“CBD”) oil products, and Supreme Cannabis expects that the facility’s capacity will reach annual production of over 7,000,000 tincture bottles by the end of calendar year 2019. “With the receipt of the License and expanded extraction capacity, Blissco will be positioned to address the growing unmet demand for high-quality CBD oil products across Canada,” Supreme Cannabis CEO Navdeep Dhaliwal said in the news release. “Blissco’s legacy of premium whole flower products established a brand that represents quality and authenticity to wellness consumers. For over a year, Blissco’s team developed advanced oil processing and formulation capabilities based on the same ethos. Consumers will soon be able to experience high-quality CBD oil products from a premium wellness brand they have come to trust. The team at Blissco has developed sophisticated expertise and diligently executed against ambitious business objectives, their hard work and vision has led to this significant milestone.”

To view the full press release, visit http://cnw.fm/FkgG0

About Supreme Cannabis

The Supreme Cannabis Company is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the company has emerged as one of the world’s fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products. Supreme Cannabis’ portfolio includes 7ACRES, its wholly-owned subsidiary and multi-award-winning brand; Blissco Cannabis Corp., a wellness cannabis brand and a multi-licensed processor and distributor based in British Columbia; Truverra Inc., a global medicinal cannabis brand and licensed cultivator; Cambium Plant Sciences, a plant genetics and cultivation IP company; Medigrow Lesotho, an cannabis oil producer located in southern Africa; Supreme Heights, an investment platform focused on CBD brands in the UK and Europe and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada. For more information, visit the company’s website at www.Supreme.ca.

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://cnw.fm/SPRWF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Provides R&D Program Update

Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today provided an update on the ongoing relationship and pursuit of innovation in oral, reduced risk nicotine consumer products using Lexaria’s patented DehydraTECH(TM) technology. According to the update, most of the investigation and work within the first phase of the project underway between Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc (NYSE:MO) and Lexaria’s majority owned subsidiary Lexaria Nicotine LLC is either complete or significantly underway, with imminent commencement of one remaining aspect. Results have been positive to date and support successful completion of this first phase. “The program between Altria and Lexaria is progressing nicely and is enabling a clearer understanding of the potential of delivering nicotine through oral forms that avoid lung absorption,” Lexaria Bioscience and Lexaria Nicotine CEO Chris Bunka said in the news release. “Lexaria strongly believes that, given the choice, many of the world’s one billion smokers would elect to experience their nicotine in a manner that does not rely on either smoking or vaping, and Lexaria can help enable these alternatives.”

To view the full press releases, visit http://cnw.fm/ZLv7o

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Announces Cancellation of PCCBD Investment

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) on Monday announced termination of the proposed investment into The Physician’s Choice CBD (“PCCBD”) of Phoenix, Arizona, as previously disclosed in April 2019. “I am disappointed to report that after many months of meetings, discussions and attempts to manage an increasingly frustrating process, Chemistree has decided that the proposed $1 million investment into what we believed was a compelling and unique company, cannot be made,” Chemistree President Karl Kottmeier said in the news release. “While scientifically excellent, our due diligence identified significant issues with PCCBD management. We ultimately determined that we could not arrive at a go forward plan, nor a definitive agreement and accordingly the proposed arrangement has been terminated, with no funds having been forwarded.”

To view the full press release, visit http://cnw.fm/jH8b7

About Chemistree Technology Inc.

Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, endeavoring to provide turn-key solutions for the regulated cannabis industry.  The company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. For more information, visit the company’s website at www.Chemistree.ca.

NOTE TO INVESTORS: The latest news and updates relating to CHMJF are available in the company’s newsroom at http://cnw.fm/CHM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Receives Health Canada Approval for Facility Expansion

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Monday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has gained Health Canada approval for a significant expansion at its Mississauga, Ontario facility. TerrAscend anticipates that the approval will assist in the company’s goal to meet the growing consumer demand for premium cannabis products and brands expected to surge as the next wave of Canadian cannabis legalization. The approval almost triples TerrAscend’s licensed space to 51,800 square feet. The new space will be comprised of supplementary cultivation capacity, a commercial kitchen, formulation rooms and larger primary and secondary packaging capacity.

To view the full press release, visit http://cnw.fm/XOf4g

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com